Literature DB >> 8557029

Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.

Y L Yang1, L F Reis, J Pavlovic, A Aguzzi, R Schäfer, A Kumar, B R Williams, M Aguet, C Weissmann.   

Abstract

Double-stranded RNA-dependent protein kinase (PKR) has been implicated in interferon (IFN) induction, antiviral response and tumor suppression. We have generated mice devoid of functional PKR (Pkr%). Although the mice are physically normal and the induction of type I IFN genes by poly(I).poly(C) (pIC) and virus is unimpaired, the antiviral response induced by IFN-gamma and pIC was diminished. However, in embryo fibroblasts from Pkr knockout mice, the induction of type I IFN as well as the activation of NF-kappa B by pIC, were strongly impaired but restored by priming with IFN. Thus, PKR is not directly essential for responses to pIC, and a pIC-responsive system independent of PKR is induced by IFN. No evidence of the tumor suppressor activity of PKR was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557029      PMCID: PMC394734          DOI: 10.1002/j.1460-2075.1995.tb00300.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  77 in total

1.  Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase.

Authors:  A E Koromilas; S Roy; G N Barber; M G Katze; N Sonenberg
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

Review 2.  The war against the interferon-induced dsRNA-activated protein kinase: can viruses win?

Authors:  M G Katze
Journal:  J Interferon Res       Date:  1992-08

3.  TIK, a novel serine/threonine kinase, is recognized by antibodies directed against phosphotyrosine.

Authors:  P L Icely; P Gros; J J Bergeron; A Devault; D E Afar; J C Bell
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

4.  Identification of double-stranded RNA-binding domains in the interferon-induced double-stranded RNA-activated p68 kinase.

Authors:  G S Feng; K Chong; A Kumar; B R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

5.  The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene.

Authors:  D Thanos; T Maniatis
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

6.  Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth.

Authors:  E F Meurs; Y Watanabe; S Kadereit; G N Barber; M G Katze; K Chong; B R Williams; A G Hovanessian
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

7.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

8.  Identification of the double-stranded RNA-binding domain of the human interferon-inducible protein kinase.

Authors:  R C Patel; G C Sen
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

9.  Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase.

Authors:  E F Meurs; J Galabru; G N Barber; M G Katze; A G Hovanessian
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

10.  Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2.

Authors:  K L Chong; L Feng; K Schappert; E Meurs; T F Donahue; J D Friesen; A G Hovanessian; B R Williams
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

View more
  260 in total

Review 1.  Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor.

Authors:  R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR.

Authors:  F Demarchi; M I Gutierrez; M Giacca
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  HSV.com: maneuvering the internetworks of viral neuropathogenesis and evasion of the host defense.

Authors:  S L Tan; M G Katze
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 4.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

5.  Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene.

Authors:  D A Leib; M A Machalek; B R Williams; R H Silverman; H W Virgin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 6.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

7.  Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.

Authors:  J Talon; C M Horvath; R Polley; C F Basler; T Muster; P Palese; A García-Sastre
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  Role for p53 in gene induction by double-stranded RNA.

Authors:  B T Hummer; X L Li; B A Hassel
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

9.  Biologic consequences of Stat1-independent IFN signaling.

Authors:  M P Gil; E Bohn; A K O'Guin; C V Ramana; B Levine; G R Stark; H W Virgin; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

10.  Protein synthesis shut-off induced by influenza virus infection is independent of PKR activity.

Authors:  T Zürcher; R M Marión; J Ortín
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.